A new drug called retatrutide helped nearly two-thirds of trial participants cut their knee pain in half. Research in the New England Journal of Medicine showed this result for adults with higher BMI. Many people in India suffer from osteoarthritis, so this weekly injection could be a useful new treatment option.
There is some good news for anyone dealing with knee pain from osteoarthritis: a new drug called retatrutide helped nearly two-thirds of trial participants cut their pain in half.
That is a big jump compared with just 38% who felt better with a placebo, according to research published in the New England Journal of Medicine.
Osteoarthritis is very common and can make everyday life tough, especially in India, where it affects up to 39% of people.
Retatrutide was tested on adults with higher BMI and painful knees using weekly injections.
The study found retatrutide may be useful for treating painful knee arthritis in people with obesity.